A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells

Experimental Cell Research

Volumn 319, Issue 10, 2013, Pages 1482-1490

  Jin, Feng zhen ^a,b   Yu, Chao ^b   Zhao, De zhang ^b   Wu, Ming jun ^b   Yang, Zhu ^a,b  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Cell migration; E cadherin; O GlcNAcylation; O linked N acetylglucosamine transferase; Ovarian cancer

Indexed keywords

SMALL INTERFERING RNA; UVOMORULIN;

ARTICLE; BIOTRANSFORMATION; CANCER CELL CULTURE; CELL ASSAY; CELL MIGRATION; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INHIBITION KINETICS; NUCLEOTIDE SEQUENCE; O GLCNACYLATION; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; RNA EXTRACTION;

EID: 84877921283     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.03.013     Document Type: Article

References (44)

1. Yuchao Gu, Wenyi Mi, Yuqing Ge, Haiyan Liu, Qiong Fan, Cuifang Han, Jing Yang, Feng Han, Xinzhi Lu, Wengong Yu GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res. 2010, 70:6344-6351.
2. Wells L., Vosseller K., Hart G.W. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell Mol. Life Sci. 2003, 60:222-228.
3. McClain D.A., Crook E.D. Hexosamines and insulin resistance. Diabetes 1996, 45:1003-1009.
4. McClain D.A., Lubas W.A., Cooksey R.C., Hazel M., Parker G.J., Love D.C., Hanover J.A. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:10695-10699.
5. Park S.Y., Ryu J., Lee W. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces in sulin resistance in rat primary adipocytes. Exp. Mol. Med. 2005, 37:220-229.
6. Yang X., Ongusaha P.P., Miles P.D., Havstad J.C., Zhang F., So W.V., Kudlow J.E., Michell R.H., Olefsky J.M., Field S.J., Evans R.M. Phosphoinositide signalling links O-GlcNActransferase to insulin resistance. Nature 2008, 451:964-969.
7. Buse M.G. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E1-E8.
8. Wice B.M., Trugnan G., Pinto M., Rousset M., Chevalier G., Dussaulx E., Lacroix B., Zweibaum A. The intracellular accumulation of UDP-N-acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate. J. Biol. Chem. 1985, 260:139-146.
9. Yang W.H., Kim J.E., Nam H.W., Ju J.W., Kim H.S., Kim Y.S., Cho J.W. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 2006, 8:1074-1083.
10. Sherr C.J., McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002, 2:103-112.
11. Chou T.Y., Hart G.W., Dang C.V. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 1995, 270:18961-18965.
12. Chou T.Y., Dang C.V., Hart G.W. Glycosylation of the c-Myc transactivation domain. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4417-4421.
13. Kawauchi K., Araki K., Tobiume K., Tanaka N. Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3431-3436.
14. Erturk-Hasdemir D., Broemer M., Leulier F., Lane W.S., Paquette N., Hwang D., Kim C.H., Stoven S., Meier P., Silverman N. Two roles for the Drosophila IKK complex in the activation of Relish and the induction of antimicrobial peptide genes. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9779-9784.
15. Lee H.H., Jan L.Y., Jan Y.N. Drosophila IKK-related kinase Ik2 and Katanin p60-like 1 regulate dendrite pruning of sensory neuron during metamorphosis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6363-6368.
16. Park S.Y., Kim H.S., Kim N.H., Ji S., Cha S.Y., Kang J.G., Ota I., Shimada K., Konishi N., Nam H.W., Hon S.W., Yang W.H., Roth J., Yook JI, Cho J.W. Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J. 2010, 29:3787-3796.
17. Caldwell S.A., Jackson S.R., Shahriari K.S., Lynch T.P., Sethi G., Walker S., Vosseller K., Reginato M.J. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene 2010, 29:2831-2842.
18. Jochmann R., Thurau M., Jung S., Hofmann C., Naschberger E., Kremmer E., Harrer T., Miller M., Schaft N., Sturzl M. O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter. J. Virol. 2009, 83:3704-3718.
19. Ozcan S., Andrali S.S., Cantrell J.E. Modulation of transcription factor function by O-GlcNAc modification. Biochim. Biophys. Acta 2010, 1799:353-364.
20. Slawson C., Zachara N.E., Vosseller K., Cheung W.D., Lane M.D., Hart G.W. Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J. Biol. Chem. 2005, 280:32944-32956.
21. Krzeslak A., Forma E., Bernaciak M., Romanowicz H., Brys M. Gene expression of O-GlcNAc cycling enzymes in human breast cancers. Clin. Exp. Med. 2011, 12:61-65.
22. Hu P., Berkowitz P., Madden V.J., Rubenstein D.S. Stabilization of plakoglobin and enhanced keratinocyte cell-cell adhesion by intracellular O-glycosylation. J. Biol. Chem. 2006, 281:12786-12791.
23. Zhu W., Leber B., Andrews D.W. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J. 2001, 20:5999-6007.
24. Wenyi Mi Yuchao, Gu Cuifang, Han Haiyan, Liu Qiong, Fan Xinling, Zhang Qi Cong, Wengong Yu. O-GlcNAcylation is a novel regulator of lung and colon cancer Malignancy. Biochim. Biophys. Acta 2011, 1812:514-519.
25. Lynch Thomas P., Ferrer Christina M., RaElle Jackson S., Shahriari Kristina S., Vosseller Keith, Reginato Mauricio J. Critical role of O-GlcNAc transferase in prostate cancer invasion, angiogenesis and metastasis. J. Biol. Chem. 2012, 287:11070-11081.
26. Wang Z., Banerjee S., Kong D., Li Y., Sarkar F.H. Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res. 2007, 67:8293-8300.
27. Shi Y., Tomic J., Wen F., Shaha S., Bahlo A., Harrison R., Dennis J.W., Williams R., Gross B.J., Walker S., Zuccolo J., Deans J.P., Hart G.W., Spaner D.E. Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia 2010, 24:1588-1598.
28. Gu Y., Ande S.R., Mishra S. Altered O-GlcNAc modification and phosphorylation of mitochondrial proteins in myoblast cells exposed to high glucose. Arch. Biochem. Biophys. 2011, 505:98-104.
29. Yehezkel G., Cohen L., Kliger A., Manor E., Khalaila I. O-Linked beta-N-Acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-Acetyl-beta-D-glucosaminidase silencing on cell phenotype and transcriptome. J. Biol. Chem. 2012, 287:28755-28769.
30. Zhu Q., Zhou L., Yang Z., Lai M., Xie H., Wu L., Xing C., Zhang F., Zheng S. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med. Oncol. 2011, 29:985-993.
31. Kikkawa F., Matsuzawa K., Arii Y., Kawai M., Kobayashi I., Nakashima N., Mizutani S. Randomized trial of cisplatin and carboplatin versus cisplatin, vinblastine and bleomycin in ovarian cancer. Gynecol. Obstet. Invest. 2000, 50:269-274.
32. Kwak Tae Kyoung, Kim Hyeonjung, Jung Oisun, Lee Sin-Ae, Kang Minkyung, Kim Hyun Jeong, Park Ji-Min, Kim Sung-Hoon, Lee Jung Weon Glucosamine treatment-mediated O-GlcNAc modification of paxillin depends on adhesion state of rat insulinoma INS-1 Cells. J. Biol. Chem. 2010, 285:36021-36031.
33. Sayat R., Leber B., Grubac V., Wiltshire L., Persad S. O-GlcNAc-glycosylation of β-catenin regulates its nuclear localization and transcriptional activity. Exp. Cell Res. 2008, 314:2774-2787.
34. Zachara N.E., Hart G.W. The emerging significance of O-GlcNAc in cellular regulation. Chem. Rev. 2002, 102:431-438.
35. Zeidan Q., Hart G.W. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J. Cell Sci. 2010, 123:13-22.
36. Chatham J.C., Not L.G., Fulop N., Marchase R.B. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma. Shock 2008, 29:431-440.
37. Hart G.W., Housley M.P., Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007, 446:1017-1022.
38. Gavert N., Ben-Shmuel A., Lemmon V., Brabletz T., Ben-Ze'ev A. Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J. Cell Sci. 2010, 123:2135-2143.
39. Pokutta S., Weis W.I. Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu. Rev. Cell Dev. Biol. 2007, 23:237-261.
40. Chen Y.T., Stewart D.B., Nelson W.J. Coupling assembly of the E-cadherin/β-catenin complex to efficient endoplasmic reticulum exit and basal-lateal membrane targeting of E-cadherin in polarized MDCK cells. J. Cell. Biol. 1999, 144:687-699.
41. Thoreson M.A., Anastasiadis P.Z., Daniel J.M., Ireton R.C., Wheelock M.J., Johnson K.R., Hummingbird D.K., Reynolds A.B. Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J. Cell. Biol. 2000, 148:189-202.
42. Ireton R.C., Davis M.A., van Hengel J., Mariner D.J., Barnes K., Thoreson M.A., Anastasiadis P.Z., Matrisian L., Bundy L.M., Sealy L., Gilbert B., van Roy F., Reynolds A.B. A novel role for p120 catenin in E-cadherin function. J. Cell. Biol. 2002, 159:465-476.
43. Xiao K., Oas R.G., Chiasson C.M., Kowalczyk A.P. Role of p120-catenin in cadherin trafficking. Biochim. Biophys. Acta 2007, 1773:8-16.
44. Lazarus M.B., Nam Y., Jiang J., Sliz P., Walker S. Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature 2011, 469:564-567.